Clinical course of human epithelial-type malignant pleural mesothelioma replicated in an orthotopic-transplant nude mouse model

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 633-640

  Colt, Henri G ^a,d   Astoul, Philippe ^a   Wang, Xiaoen ^a   Yi, Eunhee S ^b   Boutin, Christian ^a   Hoffman, Robert M ^a,c  

^a UCSD MEDICAL CENTER   (United States)

^b Anti Cancer Inc   (United States)

^c HÔPITAL DE LA CONCEPTION   (France)

^d CSD Medical Center   (United States)

Author keywords

Epithelial type malignant pleural mesothelioma; Human; Orthotopic transplant nude mouse model

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER MODEL; CANCER TRANSPLANTATION; CASE REPORT; DISEASE COURSE; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PLEURA BIOPSY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; THORACOSCOPY;

ADULT; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LYMPHATIC METASTASIS; MALE; MESOTHELIOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PLEURAL NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030013376     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Antman KH: Clinical presentation and natural history of benign and malignant mesothelioma. Semin Oncol 8: 313-320, 1981.
2. Ruffie P: Chemotherapy of malignant mesothelioma. In: Jaurand MC, Bignon J eds. The mesothelial cell and mesothelioma. Lung Biology in Health and Disease vol 78, pp 269-284. Marcel Dekker, New York 1994.
3. Davis JMG: Experimental and spontaneous mesotheliomas. In: Jaurand MC, Bignon J eds. The mesothelial cell and mesothelioma. Lung Biology in Health and Disease vol 78, pp 187-206. Marcel Dekker, New York, 1994.
4. Davis JMG, Bolton RE, Donaldson K, Jones AD, Miller B: Inhalation studies on the effects of tremolite and brucite dust in rats. Carcinogenesis 6: 667-674, 1985.
5. Davis JMG, Jones AD, Miller BG: Experimental studies in rats on the effects of asbestos inhalation coupled with the inhalation of titanium dioxide or quartz. Int J Exp Pathol 72:501-525, 1991.
6. Davis JMG, Jones AD. Comparisons of the pathogenicity of long and short fibers of crysotile asbestos in rats. Br J Exp Pathol ;69:717, 1988.
7. Hesterberg TW, Mast R, McConnell EE, Chevalier J, Bernstein DM, Burn WB, Anderson R: Chronic inhalation toxicity of refractory ceramic fibers in Syrian hamsters. In: Brown RC, Hoskins JA, Johnson NF eds. Mechanisms of fiber carcinogenesis. NATO ASI Ser [A] ; 221: 519-539, 1992.
8. Fidler IJ: Critical factors in the biology of human cancer metastasis. Cancer Res 50: 6130-6138, 1990.
9. Hoffman RM: Histoculture and the immunodeficient mouse come to the cancer clinic: rational approaches to individualizing cancer therapy and new drug evaluation. Int J Oncol 1: 467-474, 1992.
10. Astoul P, Colt HG, Wang X, Boutin C, Hoffman RM: Patient-like nude mouse metastatic model of advanced human pleural cancer. J Cell Biochem 56: 9-15, 1994.
11. Astoul P, Colt HG, Wang X, Hoffman RM: A patient-like nude mouse model of parietal pleura human adenocarcinoma. Anticancer Res 14: 85-91, 1994.
12. Boutin C, Rey F, Viallat JR, Astoul P, Ledoray V: Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 patients. Cancer 72: 389-404, 1993.
13. Kyriazis A, Kyriazis AP: Preferential sites of growth of human tumors in nude mice following subcutaneous transplantation. Cancer Res 40: 4509-4511, 1980.
14. Hsu SM, Raine L, Fanger H: The use of antiavidin antibody and antibiotin-peroxidase complex in immunoperoxidase techniques. Am J Clin Pathol 75: 816-821, 1981.
15. Pisani RJ, Colby TV, Williams DE: Malignant mesothelioma of the pleura. Mayo Clin Proc 63: 1234-1244, 1988.
16. Nicholson NJ, Perkel G, Selikoff IJ: Occupational exposure to asbestos: population at risk and projected mortality 1980-2030. Am J Ind Med 3: 259-311, 1982.
17. Alberts A, Falkson G, Goedhals L, Vorobiof D, van der Merwe C: Malignant mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol 6: 527-536, 1988.
18. Ruffie P, Feld R, Minkin S, Cormier Y, Bontan-laroze A, Ginsssberg et al: Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 7: 1157-1168, 1989.
19. Wagner JC, Skidmore JW, Grifiths DM: Erionite exposure and mesotheliomas in rats. Br J Cancer 51: 727-730, 1985.
20. Holiat SM, Smith WE, Hubert DD, Davis S: Chemotherapeutic trials with hamster mesothelioma 10-24. response to azacytidine, aziridinyl-benzoquinone, cisplatin and PCNU. Cancer Treat Rep 65: 1113-1115, 1981.
21. Chahinian AP, Beranek JT, Suzuki Y, Bekesi G, Wisniewski L, Selikoff IJ, Holland JF: Transplantation of human malignant mesothelioma into nude mice. Cancer Res 40: 181-185, 1980.
22. Arnold W, Naundorf H, Wilder GP, Nissen E, Tanneberger S: Biological characterization of mesothelioma line in nude mice. Tansplantation of in vitro cultivated cells of a human ascitic tumor effusion. Arch Geschwulstforsch 49: 495-507, 1979.
23. Smythe WR, Kaiser LR, Hwang HC, Amin KM, Pilewski JM, Eck SJ, Wilson JM, Albelda SM: Successful adenovirus-mediated gene transfer in an in vivo model of malignant mesothelioma. Ann Thorac Surg 57: 1395-1401, 1994.
24. Suzuki Y, Chahinian AP, Ohnuma T: Comparative studies of human malignant mesothelioma in vivo, in xenografts in nude mice, and in vitro: cell origin of malignant mesothelioma. Cancer 60: 334-344, 1987.
25. Linden CJ, Johansson L: Progressive growth of a human pleural mesothelioma xenografted to athymic rats and mice. Br J Cancer 58: 614-618, 1988.
26. Chahinian AP, Norton L, Holland JF, Szrajer L, Hart RD: Experimental and clinical activity of mitomycin C and cis-Diamminedichloroplatinum in malignant mesothelioma. Cancer Res 44: 1688-1692, 1984.
27. Chahinian AP, Kirschner PA, Gordon RE, Szrajer L, Holland JF: Usefulness of the nude mouse model in mesothelioma based on direct patient-xenograft comparison. Cancer 68: 558-560, 1991.
28. Giovanell BC, Stehlin JS, WilliamLJ, Lee SS, Shepard RC: Heterotransplantation of human cancers into nude mice. A model system for human chemotherapy. Cancer 42: 2269-2281, 1978.
29. Buhl L, Dragsholt C, Svendsen P, Hage E, Buhl MR: Urinary hypoxanthine andpsuclouridine as indicators of tumor development in mesothelioma transplanted nude mice. Cancer Res 45: 1159-1162, 1985.
30. Sklarin NT, Chahinian AP, Feuer EJ, Lahman LA, Szrajer L, Holland JF: Augmentation of activity of cis-diamminedichloroplatinum (II) and mitomycin C by interferon in human malignant mesothelioma xenografts in nude mice. Cancer Res 48: 64-67, 1988.
31. Lee JM, Bruckner HW, Szrajer L, Brenne U, Schindelheim G, Andreotti PE: Taxol inhibits growth of mesothelioma xenografts. Anticancer Res 15: 693-696, 1995.
32. Johnson JR, Hammond WG, Benfield JR, Tesluk H: Successful xenotransplantation of human lung cancer correlates with the metastatic phenotype. Ann Thorac Surg 60: 32-37, 1995.
33. Bohlman ME, Liu MC, Fine DL, Mayo JG, Boyd MR: Comparison of intrapulmonary, percutaneous intrathoracic, and subcutaneous models for the propagation of human pulmonary and nonpulmonary cancer cell lines in athymic nude mice. Cancer Res 48: 2880-2886, 1966.
34. Chahinian AP: The nude mouse model in mesothelioma research and therapy. Eur Respir Rev 3: 204-207, 1993.
35. Wilmans C, Fan D, O'Brian CA, Bucana CD, Fidler IJ: Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer 52: 98-104, 1992.
36. Hoffman RM: Orthotopic is orthodox: Why are orthotopic transplant metastatic models different from all other models ? J Cell Biochem 56: 1-3, 1994.
37. Furukawa T, Fu X, Kubota T, Watanbe M, Kitajama M and Hoffman RM: Nude mouse metastatic models of human stomach cancer constructed using orthotopic transplantation of histologically intact tissue. Cancer Res 53., 53: 1204-1208, 1993.
38. Fu X, Besterman JM, Monosov A and Hoffman RM: Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically-intact patient specimens. Proc Natl Acad Sci USA 88: 9345-9349, 1991.
39. Hoffman RM: Patient-like models of cancer in mice. Curr Perspect Mol Cell Oncol 1: 311-326, 1992.
40. Wang X, Fu X, Kubota T, Hoffman RM: A new patient-like metastatic model of human small cell lung cnacer constructed orthotopically with intact tissue via thoracotomy in nude mice. Anticancer Res 12: 1402-1406, 1992.
41. Astoul P, Wang X, Hoffman R: ́Patient-liké nude and SCID-mouse models of human lung and pleural cancer (review). Int J Oncol 3: 713-7181, 1993.
42. Togo S, Shimada H, Kubota T, Moossa AR, Hoffman RM: Host organ specifically determine cancer progression. Cancer Res 55: 681-684, 1995.